St. Jude Medical, Inc.

Medical device company discontinues symmetry bypass aortic product line

Published in Biotech Law Weekly, October 29th, 2004

St. Jude Medical, Inc. (STJ) announced that it intends to discontinue its Symmetry Bypass System Aortic Connector product line, but will continue to provide ongoing product, technical and physician support for these devices.

"While we have been pleased with the clinical performance and technical advances offered by the Symmetry Anastomotic device, and continue to believe in the value this technology provides, business conditions in this area have proven to be increasingly challenging," said George J. Fazio, president, Cardiac Surgery Division.

"We will continue to support our customers and their patients," said Fazio. "As part of these efforts,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Law Weekly

Source: Biotech Law Weekly (2004-10-29)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry